Inventor
LIM AI CHING
US27 patents
⚠️ This page may combine multiple inventors who share the name “LIM AI CHING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
10 patentsUS7767206B2Aug 3, 2010
Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
AMGEN INC76 citations98
US9382318B2Jul 5, 2016
ST2 antigen binding proteins
AMGEN INC10 citations92
US10851144B2Dec 1, 2020
Interleukin-2 muteins for the expansion of T-regulatory cells
AMGEN INC16 citations89
US9982054B2May 29, 2018
ST2 antigen binding proteins
AMGEN INC4 citations83
US11059895B2Jul 13, 2021
ST2 antigen binding proteins
AMGEN INC2 citations72
US9309318B2Apr 12, 2016
Compositions relating to anti-IL-21 receptor antibodies
AMGEN INC4 citations72
US11965029B2Apr 23, 2024
ST2 antigen binding proteins
AMGEN INC0 citations62
US11976103B2May 7, 2024
Interleukin-2 muteins for the expansion of T-regulatory cells
AMGEN INC0 citations58
US10227414B2Mar 12, 2019
ST2 antigen binding proteins
AMGEN INC0 citations51
US10184002B2Jan 22, 2019
Methods and compositions relating to anti-IL-21 receptor antibodies
AMGEN INC0 citations51
BRISTOL MYERS SQUIBB CO
5 patentsUS7858739B2Dec 28, 2010
Inhibitors of type 2 vascular endothelial growth factor receptors
BRISTOL MYERS SQUIBB CO84 citations98
US7847062B2Dec 7, 2010
Pharmacokinetic modulation and compositions for modified FN3 polypeptides
BRISTOL MYERS SQUIBB CO77 citations98
US9328157B2May 3, 2016
Inhibitors of type 2 vascular endothelial growth factor receptors
BRISTOL MYERS SQUIBB CO26 citations97
US9862758B2Jan 9, 2018
Inhibitors of type 2 vascular endothelial growth factor receptors
BRISTOL MYERS SQUIBB CO20 citations94
US10995131B2May 4, 2021
Libraries of modified fibronectin type III tenth domain-containing polypeptides
BRISTOL MYERS SQUIBB CO1 citations73
KINIKSA PHARMACEUTICALS LTD
5 patentsUS9593163B2Mar 14, 2017
Oncostatin M receptor antigen binding proteins
KINIKSA PHARMACEUTICALS LTD5 citations81
US10421813B2Sep 24, 2019
Oncostatin M receptor antigen binding proteins
KINIKSA PHARMACEUTICALS LTD1 citations70
US9663571B2May 30, 2017
Oncostatin M receptor antigen binding proteins
KINIKSA PHARMACEUTICALS LTD3 citations70
US12122837B2Oct 22, 2024
Oncostatin M receptor antigen binding proteins
KINIKSA PHARMACEUTICALS LTD0 citations60
US9738721B1Aug 22, 2017
Oncostatin M receptor antigen binding proteins
KINIKSA PHARMACEUTICALS LTD1 citations60